Remote interactive evaluations: FDA official discusses lessons learned
Regulatory NewsJoanne S. EglovitchBiologics/ biosimilars/ vaccinesBiotechnologyChemistry, Manufacturing and Controls (CMC)ComplianceNorth AmericaOTCPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/Policy